The Mumbai-based pharma major#39;s revenue during the same quarter last year stood at Rs 972 crore.
Ajanta Pharma Q3 net profit jumps 56% YoY to Rs 210 crore, revenue up 14% on January 31, 2024 at 11:01 am
The Mumbai-based pharma major#39;s revenue during the same quarter last year stood at Rs 972 crore.
Consolidated net revenue in the October-December quarter declined 5.9 percent to Rs 11,736 crore amid lower volumes
All Nifty sectoral indices were trading in green, with pharma, auto leading the pack. Nifty Bank, PSU bank, metal, energy and FMCG indices were trading up to a percent higher
The biggest Nifty gainers included Dr Reddy#39;s Laboratories, Eicher Motors, Sun Pharma, Divis Labs, Tata Motors, while losers were LT, Titan Company, Tata Consumer and BPCL
The overall global gold demand was 4,699 tonnes in 2022, according to WGC#39;s Gold Demand Trends report 2023. According to the report, global gold ETFs saw a third consecutive annual outflow, losing 244.4 tonnes compared to 109.5 tonnes in 2022.
NULL
Much of the work and legacies of previous Finance Commissions is getting lost because it isn’t a permanent body. Administrative difficulties also abound. A provisional solution is to turn the Finance Commission Division (FCD), as the custodian of FC records and responsible for its award implementation, to be turned into full-fledged department, serving as the… Continue reading How the Finance Commission can be strengthened on January 31, 2024 at 9:04 am
In today#39;s edition of Moneycontrol Pro Panorama: Evergrande crisis not a big deal, most investors know Budget is a stock market trigger, Finance Minster#39;s excellent fiscal record, government to focus more on agriculture sector, and more
Officials are likely to keep interest rates unchanged at the conclusion of their January meeting. Here’s a look at what might come next.
Sectorally, Nifty Pharma led the gains, rising nearly 2 percent. Nifty Bank, too, was up over a percent, as the market waits for finance minister Nirmala Sitharaman#39;s interim budget, which she will present on February 1